A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–reperfusion injury

F Fiordaliso, S Chimenti… - Proceedings of the …, 2005 - National Acad Sciences
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

[HTML][HTML] A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–reperfusion injury

F Fiordaliso, S Chimenti, L Staszewsky… - Proceedings of the …, 2005 - ncbi.nlm.nih.gov
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

[PDF][PDF] A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–reperfusion injury

F Fiordaliso, S Chimenti, L Staszewsky, A Bai, E Carlo… - PNAS, 2005 - academia.edu
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–
reperfusion injury Page 1 A nonerythropoietic derivative of erythropoietin protects the …

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–reperfusion injury

F Fiordaliso, S Chimenti, L Staszewsky, A Bai… - Proceedings of the …, 2005 - cir.nii.ac.jp
抄録< jats: p> The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in
part by preventing apoptosis. However, EPO administration can also raise the hemoglobin …

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

F Fiordaliso, S Chimenti, L Staszewsky, A Bai… - … OF THE NATIONAL …, 2005 - ora.uniurb.it
: The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

F Fiordaliso, S Chimenti, L Staszewsky… - Proceedings of the …, 2005 - ui.adsabs.harvard.edu
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.

F Fiordaliso, S Chimenti, L Staszewsky… - Proceedings of the …, 2005 - europepmc.org
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

A Nonerythropoietic Derivative of Erythropoietin Protects the Myocardium from Ischemia-Reperfusion Injury

F Fiordaliso, S Chimenti, L Staszewsky, A Bai… - Proceedings of the …, 2005 - JSTOR
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

F Fiordaliso, S Chimenti… - Proceedings of the …, 2005 - pubmed.ncbi.nlm.nih.gov
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by
preventing apoptosis. However, EPO administration can also raise the hemoglobin …

[PDF][PDF] A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–reperfusion injury

F Fiordaliso, S Chimenti, L Staszewsky, A Bai, E Carlo… - PNAS, 2005 - researchgate.net
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–
reperfusion injury Page 1 A nonerythropoietic derivative of erythropoietin protects the …